Cargando…
Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer’s disease
BACKGROUND: Soluble triggering receptor expressed on myeloid cells 2 (sTREM2) plays an important role in the clearance of pathological amyloid-β (Aβ) in Alzheimer’s disease (AD). This study aimed to explore sTREM2 as a central and peripheral predictor of the conversion from mild cognitive impairment...
Autores principales: | Zhao, Aonan, Jiao, Yang, Ye, Guanyu, Kang, Wenyan, Tan, Lan, Li, Yuanyuan, Deng, Yulei, Liu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753995/ https://www.ncbi.nlm.nih.gov/pubmed/36519540 http://dx.doi.org/10.1172/JCI158708 |
Ejemplares similares
-
Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer’s dementia
por: Zhao, Aonan, et al.
Publicado: (2020) -
Visual Abnormalities Associate With Hippocampus in Mild Cognitive Impairment and Early Alzheimer's Disease
por: Zhao, Aonan, et al.
Publicado: (2021) -
Association of rs2062323 in the TREM1 gene with Alzheimer's disease and cerebrospinal fluid‐soluble TREM2
por: Wang, Zuo‐Teng, et al.
Publicado: (2023) -
Predictive models for mild cognitive impairment to Alzheimer’s disease conversion
por: Skolariki, Konstantina, et al.
Publicado: (2021) -
The Impact of Frailty on the Risk of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease: Evidences from a 5-Year Observational Study
por: Trebbastoni, Alessandro, et al.
Publicado: (2017)